Kinnevik leads a EUR 40 million funding round in Tandem Health, a Swedish company focused on developing AI-driven solutions for clinical workflows.
Information on the Target
Tandem Health is a Swedish healthcare infrastructure company that is at the forefront of incorporating artificial intelligence into clinical workflows. The organization is focused on developing a medical AI scribe designed to alleviate administrative burdens on healthcare providers, thereby improving efficiency and patient care. This innovative tool aims to streamline the documentation process, allowing clinicians to focus more on patient interactions rather than paperwork.
The company has demonstrated a clear vision of building a comprehensive European operating system specifically for clinical workflows, positioning itself as a leader in the healthcare tech space. With the increasing reliance on technology to solve challenges in healthcare, Tandem Health stands out as a significant player poised for growth and transformation within the industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
The healthcare technology sector in Sweden has been rapidly evolving, driven by technological advancements and a growing demand for efficient healthcare solutions. The country boasts a robust healthcare infrastructure supported by significant governme
Similar Deals
Kinnevik
invested in
Tandem Health
in 2025
in a Other VC deal
Disclosed details
Revenue: $275M